Stock SIGHT GENSIGHT BIOLOGICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GenSight Biologics S.A.

Equities

SIGHT

FR0013183985

Market Closed - Euronext Paris
Other stock markets
 11:35:27 2024-05-31 am EDT 		5-day change 1st Jan Change
0.363 EUR -0.82% Intraday chart for GenSight Biologics S.A. -6.80% -21.09%
May. 07 GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding CI
Apr. 05 GenSight: financial visibility assured until the end of April CF

Evolution of the average Target Price on GenSight Biologics S.A.

Price target over the last 5 years

History of analyst recommendation changes

c8941e1a7d05.a84kwpPBbLRkv1DB1xluxF7mL1KdI0UyMW5trrpn30g.D6hUmKSSXN0u1AOYpClXhWmMXib5RBBTA180-NUL6g9fpVWr95En5DLyGQ~9ab03eb23b143063335d54351963d90a

Analyst Recommendations on GenSight Biologics S.A.

GENSIGHT : Degroof Petercam initiates buy coverage CF
GENSIGHT BIOLOGICS : Oddo maintains its recommendation despite delays CF
GENSIGHT : Oddo confirms its recommendation on the stock CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.363 EUR
Average target price
0.4 EUR
Spread / Average Target
+10.19%
High Price Target
0.4 EUR
Spread / Highest target
+10.19%
Low Price Target
0.4 EUR
Spread / Lowest Target
+10.19%

Consensus detail

Consensus revision (last 18 months)

Ratings for GenSight Biologics S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SIGHT Stock
  4. Consensus GenSight Biologics S.A.